Building natural products
Natural products are molecules produced by living organisms and include some of our most powerful drugs. Emerging discoveries in this field have allowed scientists to deepen our understanding of how natural products are assembled and how they can be harnessed for widespread applications.
Submit an abstract
Abstract submission begins Sept. 14. If you submit by Oct. 12, you'll get a decision by Nov. 1. The regular submission deadline is Nov. 30. See the categories.
This program at Discover BMB 2024 is focused on recent advances in natural product biochemistry and biotechnology. The first session focuses on the emerging area of natural products from higher eukaryotes and animals; the second session focuses on natural products from microbiomes and symbionts; and the final session focuses on the biochemistry and biotechnology of natural product genome mining.
We’ll hear about the amazing discoveries in this field, some of which were powered by major technological advances. We’ll also hear how discoveries in natural products biochemistry are now in turn powering new applications in biotechnology related to biocatalysis, agriculture and sustainable chemical production.
Keywords: Natural products, biocatalysis, microbiome.
Who should attend: Anyone interested in natural products, biocatalysis, the microbiome or the future of biotechnology.
Theme song: “White Rabbit” by Jefferson Airplane
This session is powered by alkaloids.
Advances in natural products biochemistry and technology
Natural products from higher eukaryotes and animals
Chair: Yi Tang
Bradley Moore, University of California, San Diego

Rebecca Butcher, University of Florida
Emily Derbyshire, Duke University
Jing-Ke Weng, Whitehead Institute for Biomedical Research
Natural products from microbiomes and symbionts
Chair: Katherine Ryan
Jason Crawford, Yale University
Nancy Keller, University of Wisconsin—Madison
Alessandra Eustaquio, University of Illinois Chicago
Mohammad Seyedsayamdost, Princeton University
Biochemistry and biotechnology of natural product genome mining
Chair: Alessandra Eustaquiol
Jamie Link, Princeton University
Katherine Ryan, University of British Columbia
Gerald Wright, McMaster University
Yi Tang, University of California, Los Angeles
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

How Alixorexton could transform narcolepsy treatment
A new investigational drug, alixorexton, targets the brain’s orexin system to restore wakefulness in people with narcolepsy type 1. Alkermes chemist Brian Raymer shares how molecular modeling turned a lab idea into a promising phase 3 therapy.

Phosphatases and pupils: A dual legacy
Yale professor Anton Bennett explores how protein tyrosine phosphatases shape disease, while building a legacy of mentorship that expands opportunity and fuels discovery in biochemistry and molecular biology.

Extracellular vesicles offer clues to cattle reproduction
Extracellular vesicles from pregnant cattle support embryo development better than laboratory models, highlighting their potential to improve reproductive efficiency in bovine embryo cultures. Read more about this recent MCP paper.

Proteomics reveals protein shifts in diabetic eye disease
Using proteomics, researchers identified protein changes in eye fluid that mark diabetic retinopathy progression and may serve as biomarkers for vision-threatening complications. Read more about this recent MCP paper.

Protein modifications drive lung cancer resistance
New assay enriches protein modifications in a single process, enabling detection of key changes in drug-resistant lung cancer cells that may guide future therapies.

How antigen-processing proteins shape immunity
Researchers show how components of the antigen processing machinery shape the immunopeptidome, offering insights into immune regulation and cancer biology.